<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00700973</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 07-264</org_study_id>
    <nct_id>NCT00700973</nct_id>
  </id_info>
  <brief_title>Treating Violence-Prone Substance Use Disorder Patients</brief_title>
  <official_title>Treating Violence-Prone Substance Use Disorder Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is intended to help substance use disorder patients who perpetrate interpersonal
      violence against other adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      Interpersonal violence (IPV) among substance use disorder (SUD) patients is common,
      undertreated, and costly. SUD patients have high rates of perpetrating IPV, and IPV is a risk
      factor for poor response to SUD treatment. Failure to address IPV among SUD patients
      interferes with treatment effectiveness and contributes to relapse and higher rates of health
      services use. Nonetheless, SUD treatment programs typically do not include violence
      prevention interventions and few studies have examined interventions designed to prevent
      violence perpetration among SUD patients.

      Objectives:

      This trial evaluated the effectiveness of an IPV-prevention (IPV-P) intervention among
      patients entering VA SUD treatment who had perpetrated violence in the past year against
      another adult. Primary objectives were to test the hypotheses that, compared to patients
      assigned to a control condition (CC), those assigned to IPV-P would (1) improve more on
      violence and SUD outcomes, and (2) use fewer VA mental health and medical care services,
      thereby saving costs for VA. Secondary objectives were to test the hypothesis that, compared
      to patients assigned to CC, those assigned to IPV-P would improve more on legal and
      alienation problems and social resources.

      Methods:

      Patients entering VA SUD treatment who met eligibility criteria (past-year violence;
      cognitively intact) and provided informed consent were assigned to SUD usual care plus either
      a CC (N=60) or IPV-P (N=59) intervention using a recurrent institutional design. That is, the
      IPV-P and CC conditions were run in alternate 3-month periods. The manualized IPV-P group
      intervention, based on a Cognitive-Behavioral approach, consisted of 8 in-person group
      sessions over 1 month, followed by telephone calls once a month for 3 months. The manualized
      CC was designed to control for non-specific treatment effects associated with the IPV-P
      condition, i.e., counselor time and attention, peer support, patients' expectations that
      additional sessions provide benefit. It consisted of 8 in-person group sessions over 1 month
      that reviewed material covered in usual SUD treatment, but with novel methods used to deliver
      the IPV-P intervention (role-play, homework, group activities). CC included the booster
      telephone sessions (once per month for 3 months). Participants were assessed at baseline and
      end-of-intervention (4 months post-baseline) and 6 and 12 months post-intervention (i.e., 10
      and 16 months post-baseline) for primary and secondary outcomes and non-VA healthcare.
      Assessments consisted of the Addiction Severity Index (ASI, to assess Alcohol, Drugs,
      Psychiatric, and Legal functioning), the Conflicts Tactics Scale (CTS, to assess
      Psychological Aggression and Physical Assault against another adult), the Multidimensional
      Personality Questionnaire (MDQ, to assess Alienation, Stress Reaction, and Aggression), and
      the Life Stressors and Social Resources Inventory (LISRES, to assess family and friends
      resources). VA health care is being assessed with VA databases. Response rates at 4, 10, and
      16 months were 90%, 79%, and 73%, respectively, and did not differ between the IPV-P and CC
      groups. Follow-up analyses compared the IPV-P to the CC group on outcomes using analyses of
      covariance that controlled for the baseline value of the outcome.

      Status:

      We are still completing portions of this project: (1) conducting mixed effects regression
      analyses to compare the CC and IPV-P groups on primary and secondary outcomes (these analyses
      are partially completed), and (2) using data on VA health care utilization to compare the two
      groups on VA health care costs (permission to download these data has been obtained, and we
      are working with HERC investigators to download and analyze the data).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Addiction Severity Index Legal Composite</measure>
    <time_frame>One year post-intervention</time_frame>
    <description>Scores range from 0 to 1, with higher scores indicating more severe legal problems.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">141</enrollment>
  <condition>Substance-related Disorders</condition>
  <condition>Violence</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Substance use disorder usual care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interpersonal violence prevention intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interpersonal Violence Prevention Intervention</intervention_name>
    <description>This is a cognitive-behavioral approach incorporating cognitive restructuring and behavioral change.</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Substance use disorder usual care</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Entering VA substance use disorder treatment

          -  past-year violence

          -  cognitively intact

        Exclusion Criteria:

          -  Not entering VA substance use disorder treatment

          -  no past-year violence

          -  cognitively not intact
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Timko, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Palo Alto Health Care System, Palo Alto, CA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System, Palo Alto, CA</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304-1290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Timko C, Desai A, Blonigen DM, Moos BS, Moos RH. Driving while intoxicated among individuals initially untreated for alcohol use disorders: one- and sixteen-year follow-ups. J Stud Alcohol Drugs. 2011 Mar;72(2):173-84.</citation>
    <PMID>21388590</PMID>
  </results_reference>
  <results_reference>
    <citation>Blonigen DM, Timko C, Moos BS, Moos RH. Impulsivity is an independent predictor of 15-year mortality risk among individuals seeking help for alcohol-related problems. Alcohol Clin Exp Res. 2011 Nov;35(11):2082-92. doi: 10.1111/j.1530-0277.2011.01560.x. Epub 2011 Jun 1.</citation>
    <PMID>21631544</PMID>
  </results_reference>
  <results_reference>
    <citation>Makin-Byrd K, Cronkite RC, Timko C. The influence of abuse victimization on attendance and involvement in mutual-help groups among dually diagnosed male veterans. J Subst Abuse Treat. 2011 Jul;41(1):78-87. doi: 10.1016/j.jsat.2011.02.001. Epub 2011 Mar 10.</citation>
    <PMID>21396794</PMID>
  </results_reference>
  <results_reference>
    <citation>Timko C, Sutkowi A, Cronkite RC, Makin-Byrd K, Moos RH. Intensive referral to 12-step dual-focused mutual-help groups. Drug Alcohol Depend. 2011 Nov 1;118(2-3):194-201. doi: 10.1016/j.drugalcdep.2011.03.019. Epub 2011 Apr 22.</citation>
    <PMID>21515004</PMID>
  </results_reference>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2008</study_first_submitted>
  <study_first_submitted_qc>June 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <results_first_submitted>May 16, 2014</results_first_submitted>
  <results_first_submitted_qc>September 3, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 11, 2014</results_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anger</keyword>
  <keyword>psychotherapy, brief</keyword>
  <keyword>diagnosis, dual</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Usual Care</title>
          <description>Substance use disorder usual care
Usual care: Substance use disorder usual care</description>
        </group>
        <group group_id="P2">
          <title>IPV-P</title>
          <description>Interpersonal violence prevention intervention
Interpersonal Violence Prevention Intervention: This is a cognitive-behavioral approach incorporating cognitive restructuring and behavioral change.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="70"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1</title>
          <description>Substance use disorder usual care
Usual care: Substance use disorder usual care</description>
        </group>
        <group group_id="B2">
          <title>Arm 2</title>
          <description>Interpersonal violence prevention intervention
Interpersonal Violence Prevention Intervention: This is a cognitive-behavioral approach incorporating cognitive restructuring and behavioral change.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="71"/>
            <count group_id="B2" value="70"/>
            <count group_id="B3" value="141"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52" spread="8"/>
                    <measurement group_id="B2" value="51" spread="8"/>
                    <measurement group_id="B3" value="52" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Addiction Severity Index Legal Composite</title>
        <description>Scores range from 0 to 1, with higher scores indicating more severe legal problems.</description>
        <time_frame>One year post-intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Substance use disorder usual care
Usual care: Substance use disorder usual care</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>Interpersonal violence prevention intervention
Interpersonal Violence Prevention Intervention: This is a cognitive-behavioral approach incorporating cognitive restructuring and behavioral change.</description>
          </group>
        </group_list>
        <measure>
          <title>Addiction Severity Index Legal Composite</title>
          <description>Scores range from 0 to 1, with higher scores indicating more severe legal problems.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
                <count group_id="O2" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".038" spread=".049"/>
                    <measurement group_id="O2" value=".012" spread=".049"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Arm 1</title>
          <description>Substance use disorder usual care
Usual care: Substance use disorder usual care</description>
        </group>
        <group group_id="E2">
          <title>Arm 2</title>
          <description>Interpersonal violence prevention intervention
Interpersonal Violence Prevention Intervention: This is a cognitive-behavioral approach incorporating cognitive restructuring and behavioral change.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>A limitation of the trial (not a result or conclusion) is that high proportions of patients reported abstinence at baseline.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Christine Timko</name_or_title>
      <organization>VA Palo Alto Health Care System</organization>
      <phone>650-617-2746</phone>
      <email>Christine.Timko@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

